¼¼°èÀÇ PET-CT ½ºÄ³³Ê ½ÃÀå
PET-CT Scanners
»óǰÄÚµå : 1542648
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 467 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,260,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,780,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ PET-CT ½ºÄ³³Ê ½ÃÀåÀº 2030³â±îÁö 23¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 16¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ PET-CT ½ºÄ³³Ê ½ÃÀåÀº 2030³â¿¡´Â 23¾ï ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2023-2030³â CAGRÀº 5.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ °íÁ¤Çü PET-CT ½ºÄ³³Ê´Â CAGR 4.7%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 16¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÈÞ´ë¿ë/¸ð¹ÙÀÏ PET-CT ½ºÄ³³Ê ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4¾ï 3,690¸¸ ´Þ·¯, Áß±¹Àº CAGR 8.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ PET-CT ½ºÄ³³Ê ½ÃÀåÀº 2023³â¿¡ 4¾ï 3,690¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 4¾ï 9,070¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â CAGRÀº 8.3%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.6%¿Í 4.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ PET-CT ½ºÄ³³Ê ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

PET-CT ½ºÄ³³Ê º¹À⼺À» ÇØ¸í : Çö´ë ÀÇ·áÀÇ °æÀÌ

PET-CT ½ºÄ³³Ê´Â ¾çÀüÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(PET)°ú ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT)ÀÇ ±â´ÉÀ» °áÇÕÇÏ¿© Á¾ÇÕÀûÀÎ Áø´Ü ¿µ»óÀ» Á¦°øÇÏ´Â ÀÇ·á ¿µ»ó ±â¼úÀÇ ÃÖ°íºÀÀ¸·Î, PET °Ë»ç´Â ȯÀÚ¿¡°Ô ÁÖÀÔµÈ ¹æ»ç¼º ÃßÀûÀÚ¸¦ ÃßÀûÇÏ¿© ´ë»ç Ȱµ¿À» °¨ÁöÇϰí, ¸¹Àº °æ¿ì Áúº´À» ³ªÅ¸³»´Â ´ë»ç ±â´É ÀÌ»ó ºÎÀ§¸¦ °­Á¶ÇÕ´Ï´Ù. Áúº´À» ³ªÅ¸³»´Â ´ë»ç ±â´É ÀÌ»ó ºÎÀ§¸¦ °­Á¶ Ç¥½ÃÇÕ´Ï´Ù. ÇÑÆí, CT ½ºÄµÀº ¿¢½º·¹À̸¦ »ç¿ëÇÏ¿© ü³» ±¸Á¶ÀÇ »ó¼¼ÇÑ ´Ü¸é À̹ÌÁö¸¦ »ý¼ºÇϸç, PET-CT ½ºÄ³³Ê¸¦ °áÇÕÇϸé CT À̹ÌÁö°¡ Á¦°øÇÏ´Â ÇØºÎÇÐÀû ¹è°æ¿¡¼­ ´ë»çÀÌ»ó ºÎÀ§ÀÇ Á¤È®ÇÑ À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, Ź¿ùÇÑ Áø´Ü Á¤È®µµ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã³ÊÁö È¿°ú´Â Á¾¾çÇп¡¼­ ƯÈ÷ Á¾¾ç ¹ß°ß, º´±â °áÁ¤ ¹× Ä¡·á È¿°ú ¸ð´ÏÅ͸µ¿¡ µµ¿òÀÌ µÇ´Â Á¾¾çÇп¡¼­ ƯÈ÷ °¡Ä¡°¡ ³ô½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀ¸·Î PET-CT À̹Ì¡ÀÌ ¾î¶»°Ô °³¼±µÇ°í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº PET-CTÀÇ ´É·Â°ú Á¤È®µµ¸¦ Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ ±â¼ú Çõ½Å Áß Çϳª´Â µðÁöÅÐ PET °ËÃâ±âÀÇ °³¹ß·Î, ±âÁ¸ ¾Æ³¯·Î±× °ËÃâ±â¿¡ ºñÇØ °íÇØ»óµµ À̹ÌÁö¸¦ Á¦°øÇÏ°í °¨µµ¸¦ Çâ»ó½ÃÄ×½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ´õ ÀÛÀº º´º¯ÀÇ Á¶±â ¹ß°ß°ú ÃßÀûÀÚ ¼·ÃëÀÇ Á¤È®ÇÑ Á¤·®È­°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ ºñÇà½Ã°£(TOF) ±â¼úÀÌ PET-CT ½Ã½ºÅÛ¿¡ ÅëÇյǾî À̹ÌÁö ³ëÀÌÁî°¡ °¨¼ÒÇÏ°í º´º¯ÀÇ °ËÃâ·ÂÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶Ç ´Ù¸¥ Å« ¹ßÀüÀº ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÌ ÅëÇյǾî À̹ÌÁö À籸¼º, ³ëÀÌÁî Á¦°Å, ÀÚµ¿ ÆÇµ¶À» Áö¿øÇÏ¿© º¸´Ù ºü¸£°í Á¤È®ÇÑ Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÑ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ¹æ»ç¼º ÃßÀûÀÚ °³¹ßÀÇ ¹ßÀüÀ¸·Î °ËÃâ °¡´ÉÇÑ »ý¹°ÇÐÀû °úÁ¤ÀÇ ¹üÀ§°¡ È®´ëµÇ¾î ½Å°æ Áúȯ, ½ÉÇ÷°ü Áúȯ µî ¾Ï ÀÌ¿ÜÀÇ ´Ù¾çÇÑ Áúȯ¿¡ ´ëÇÑ º¸´Ù Á¤È®ÇÑ Æ¯¼º Æò°¡°¡ °¡´ÉÇØÁ³½À´Ï´Ù.

¸ÂÃãÇü ÀÇ·á¿¡¼­ PET-CTÀÇ ¿ªÇÒÀº ¹«¾ùÀΰ¡?

PET-CT ½ºÄ³³Ê´Â ¸ÂÃãÇü Ä¡·á Àü·« ¼ö¸³À» À§ÇÑ Áß¿äÇÑ Á¤º¸¸¦ Á¦°øÇϹǷΠ¸ÂÃãÇü ÀÇ·á¿¡¼­ PET-CT ½ºÄ³³ÊÀÇ ¿ªÇÒÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. Á¾¾çÇп¡¼­ PET-CT ¿µ»óÁø´ÜÀº Á¾¾çÀÇ ºÐÀÚÀû Ư¼ºÀ» ÆÄ¾ÇÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ÀÓ»óÀÇ´Â ¾ÏÀÇ Æ¯Á¤ ´ë»ç Ȱµ¿¿¡ µû¶ó °¡Àå È¿°úÀûÀÎ Ä¡·á¹ýÀ» ¼±ÅÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº Ä¡·áÀÇ È¿°ú¸¦ ³ôÀÌ°í ºÒÇÊ¿äÇÑ °³ÀÔÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ PET-CT´Â ³úÀÇ ´ë»ç º¯È­¸¦ Á¶±â¿¡ °¨ÁöÇÏ¿© ¾ËÃ÷ÇÏÀ̸Ӻ´°ú °°Àº ½Å°æ ÁúȯÀ» Æò°¡Çϴµ¥µµ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¶±â ¹ß°ß ´É·ÂÀº Áúº´ÀÇ ÁøÇàÀ» ´ÊÃß±â À§ÇØ Àû½Ã¿¡ °³ÀÔÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ½ÉÀ庴Çп¡¼­ PET-CT´Â ½É±ÙÀÇ »ýÁ¸À²°ú °ü·ù¸¦ Æò°¡Çϰí Ç÷¾× Àç°Ç¼ú¿¡ ´ëÇÑ °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀ» ÁÖ¸ç, ÇÑ ¹øÀÇ ÃÔ¿µÀ¸·Î ´ë»ç ¹× ÇØºÎÇÐÀû Á¤º¸¸¦ ÅëÇÕÇÒ ¼ö ÀÖ´Â PET-CT´Â º¸´Ù Á¤¹ÐÇÏ°í °³º°È­µÈ ȯÀÚ Ä¡·á¸¦ À§ÇÑ ¿òÁ÷ÀÓ¿¡ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇÑ ÅøÀÔ´Ï´Ù.

PET-CT ½ºÄ³³Ê ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

PET-CT ½ºÄ³³Ê ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ù°, Àü ¼¼°è¿¡¼­ ¾Ï ¹× ±âŸ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Á¤È®Çϰí Á¶±â ¹ß°ßÀÌ °¡´ÉÇÑ Ã·´Ü ¿µ»óÁø´Ü ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µÑ°, µðÁöÅÐ °ËÃâ±â °³¹ß ¹× AI ±â¹Ý ¿µ»ó ó¸®¿Í °°Àº Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀ¸·Î PET-CT ½ºÄ³³ÊÀÇ ¼º´É°ú È¿À²¼ºÀÌ Çâ»óµÇ¾î ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ´õ¿í ¸Å·ÂÀûÀ¸·Î ´Ù°¡¼­°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¾¾çÇлӸ¸ ¾Æ´Ï¶ó ½Å°æÇÐ ¹× ¼øÈ¯±âÇÐ ºÐ¾ß·ÎÀÇ Àû¿ëÀÌ È®´ëµÇ¸é¼­ ½ÃÀå ¹üÀ§°¡ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù. Áø´Ü ´É·Â°ú ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±Çϱâ À§ÇÑ Á¤ºÎ ±¸»ó°ú ÀçÁ¤ Áö¿øµµ ½ÃÀå È®´ë¿¡ Å« ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·áÀÇ È®»êÀ¸·Î ¸ÂÃã Ä¡·á °èȹÀ» Áö¿øÇÏ´Â PET-CT ½ºÄ³³Ê¿Í °°Àº Á¤¹ÐÇÑ Áø´Ü ÅøÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î ½ÅÈï ±¹°¡µéÀÇ ÇコÄɾ ´ëÇÑ ÅõÀÚ È®´ë´Â ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. À̵é Áö¿ª¿¡¼­´Â Áõ°¡ÇÏ´Â ÀÇ·á ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ ÀÇ·á ¿µ»ó ÀÎÇÁ¶ó¸¦ ¾÷±×·¹À̵åÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 41°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global PET-CT Scanners Market to Reach US$2.3 Billion by 2030

The global market for PET-CT Scanners estimated at US$1.6 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Stationary PET-CT Scanners, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Portable / Mobile PET-CT Scanners segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$436.9 Million While China is Forecast to Grow at 8.3% CAGR

The PET-CT Scanners market in the U.S. is estimated at US$436.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$490.7 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global PET-CT Scanners Market - Key Trends and Drivers Summarized

Unveiling the Intricacies of PET-CT Scanners: A Modern Medical Marvel

PET-CT scanners represent a pinnacle in medical imaging technology, combining the capabilities of Positron Emission Tomography (PET) and Computed Tomography (CT) to provide comprehensive diagnostic images. PET scans detect metabolic activity by tracing a radioactive tracer injected into the patient, highlighting areas of abnormal metabolic function which are often indicative of disease. CT scans, on the other hand, use X-rays to produce detailed cross-sectional images of the body’s internal structures. When combined, PET-CT scanners offer unparalleled diagnostic accuracy, allowing for precise localization of metabolic abnormalities within the anatomical context provided by CT images. This synergy is particularly valuable in oncology, where it aids in tumor detection, staging, and monitoring treatment response.

How Are Technological Advances Enhancing PET-CT Imaging?

Technological advancements have significantly enhanced the capabilities and accuracy of PET-CT scanners. One notable innovation is the development of digital PET detectors, which provide higher resolution images and improved sensitivity compared to traditional analog detectors. This advancement allows for earlier detection of smaller lesions and more accurate quantification of tracer uptake. Additionally, time-of-flight (TOF) technology has been integrated into PET-CT systems, reducing image noise and improving lesion detectability. Another major improvement is the incorporation of artificial intelligence (AI) and machine learning algorithms, which assist in image reconstruction, noise reduction, and automated interpretation, leading to faster and more accurate diagnoses. Moreover, advances in radiotracer development have expanded the range of detectable biological processes, enabling more precise characterization of various diseases beyond cancer, such as neurological and cardiovascular disorders.

What Role Does PET-CT Play in Personalized Medicine?

The role of PET-CT scanners in personalized medicine is growing, as they provide critical information that guides tailored treatment strategies. In oncology, PET-CT imaging is instrumental in identifying the molecular characteristics of tumors, enabling clinicians to select the most effective therapies based on the specific metabolic activity of the cancer. This approach enhances the efficacy of treatments and minimizes unnecessary interventions. Furthermore, PET-CT is increasingly used in the assessment of neurological conditions, such as Alzheimer’s disease, by detecting early metabolic changes in the brain. This early detection capability is crucial for implementing timely interventions that can slow disease progression. In cardiology, PET-CT aids in assessing myocardial viability and perfusion, guiding decisions regarding revascularization procedures. The ability to integrate metabolic and anatomical information in a single imaging session makes PET-CT an invaluable tool in the move towards more precise and individualized patient care.

What Factors Are Driving Growth in the PET-CT Scanner Market?

The growth in the PET-CT scanner market is driven by several factors. Firstly, the increasing prevalence of cancer and other chronic diseases worldwide is fueling the demand for advanced diagnostic imaging technologies that can provide accurate and early detection. Secondly, continuous technological innovations, such as the development of digital detectors and AI-enhanced imaging, are improving the performance and efficiency of PET-CT scanners, making them more attractive to healthcare providers. Additionally, the expansion of applications beyond oncology into neurology and cardiology is broadening the market scope. Government initiatives and funding aimed at improving diagnostic capabilities and healthcare infrastructure are also playing a significant role in market expansion. Moreover, the growing adoption of personalized medicine is boosting the need for precise diagnostic tools like PET-CT scanners, which support individualized treatment planning. Lastly, increased investment in healthcare by emerging economies is creating new opportunities for market growth, as these regions upgrade their medical imaging infrastructure to meet rising healthcare demands.

Select Competitors (Total 41 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â